Measurement of Elbow Spasticity in Stroke Patients Using a Manual Spasticity Evaluator

Spasticity is often seen in patients with central nervous system lesion, such as stroke. It hinders functional movement and may induce pain. Current measures for assessing Spasticity are either quantitative but not convenient to use or convenient to use in clinics but lack of objective quantification. We developed a manual spasticity evaluator (MSE) to evaluate the spasticity quantitatively and potentially suitable for a clinical setting. Joint position and torque from 10 subjects with right hemiplegia and 9 healthy subjects were measured conveniently and used to evaluate spasticity and determine the catch angle. EMG signal was obtained from the biceps brachii and triceps brachii to corroborate the mechanical measurement of the MSE. Results showed that the MSE provided a convenient and quantitative measurement of spasticity, including presence of catch angle, increase in joint stiffness, and decrease in joint range of motion in the stroke patients, as compared with healthy subjects. EMG signals corroborated MSE assessment of the catch angle

[1]  Qiyu Peng,et al.  Measurement of ankle spasticity in children with cerebral palsy using a manual spasticity evaluator , 2004, The 26th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[2]  Werner Poewe,et al.  A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Compare the Efficacy and Safety of Three Doses of Botulinum Toxin Type A (Dysport) With Placebo in Upper Limb Spasticity After Stroke , 2000, Stroke.

[3]  Chou-Ching K. Lin,et al.  Validation of portable muscle tone measurement device for quantifying velocity-dependent properties in elbow spasticity. , 2004, Journal of electromyography and kinesiology : official journal of the International Society of Electrophysiological Kinesiology.

[4]  N. Mayer,et al.  Clinicophysiologic concepts of spasticity and motor dysfunction in adults with an upper motoneuron lesion , 1997, Muscle & nerve. Supplement.

[5]  P. Brown Pathophysiology of spasticity. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[6]  Roslyn N. Boyd,et al.  Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy , 1999 .

[7]  D. Mclellan,et al.  The effectiveness of chemical neurolysis in the treatment of lower limb muscle spasticity , 1996 .

[8]  G. Sheean,et al.  The pathophysiology of spasticity. , 2002, European journal of neurology.

[9]  B. Bhakta,et al.  Management of spasticity in stroke. , 2000, British medical bulletin.